Used in pharmaceutical synthesis as an intermediate for antimicrobial, antiviral, and antitumor agents. The compound's structure, featuring a morpholine group and bromo substituent on the 1,3,4-thiadiazole ring, supports the development of bioactive molecules, particularly in heterocyclic chemistry. It is employed in structure-activity relationship (SAR) studies of pharmaceutical lead compounds and in the design of kinase inhibitors and other enzyme-targeted drugs due to its ability to interact with biological targets through hydrogen bonding and hydrophobic interactions. Additionally, it serves as a reagent in group transfer reactions or carbon-carbon bond formation in multi-component synthesis. It also finds use in agrochemical research for developing new crop protection agents.